DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Mega JL, Braunwald E, Murphy SA. et al.
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thro.
J Am Coll Cardiol 2013;
61 (18) 1853-1859
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.